Lower urinary tract symptoms and depressive symptoms in elderly men

J Affect Disord. 2006 Nov;96(1-2):83-8. doi: 10.1016/j.jad.2006.05.013. Epub 2006 Jul 11.

Abstract

Background: To evaluate the impact of moderate to severe lower urinary tract symptoms (LUTS) on clinically significant depressive symptoms in elderly Chinese men aged 65 and above.

Methods: In a large prospective cohort of 2000 Chinese men aged 65 to 92 years of age in Hong Kong, the association between moderate to severe lower urinary tract symptoms and clinically relevant depressive symptoms was studied. After excluding men with prostate or bladder cancer or surgery, 1980 subjects provided response to a structured interviewer-administered questionnaire and physical examination. A case-control analysis was performed, comparing subjects with clinically relevant depressive symptoms (cases) to those without depressive symptoms (controls).

Results: In multiple analyses adjusting for all factors that were shown to be significantly associated with having clinically relevant depressive symptoms in the initial bivariate analyses, being widowed, divorced or single were associated with increased risk of having clinically relevant depressive symptoms. Having a history of cardiac disease, being a current smoker and the use of corticosteroid were also associated with increased risk. Having moderate to severe LUTS was significantly associated with increased odds of having clinically relevant depressive symptoms (OR: 2.40; CI: 1.68-3.43) even after adjustment.

Limitation: This study was cross-sectional and there were no clinician-based diagnostic interviews that were conducted to diagnose clinical depression and thus only clinically relevant depressive symptoms were assessed.

Conclusions: In elderly men, moderate to severe LUTS are important public health problems that are associated with increased risk of having clinically relevant depressive symptoms. These findings suggest that physicians who deal with patients with moderate to severe LUTS should consider the psychological health of their patients as this population is at risk of having clinically relevant depressive symptoms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adrenal Cortex Hormones / adverse effects
  • Aged
  • Aged, 80 and over
  • Alcohol Drinking / adverse effects
  • Alcohol Drinking / epidemiology
  • Alcohol Drinking / psychology
  • Comorbidity
  • Coronary Disease / diagnosis
  • Coronary Disease / epidemiology
  • Coronary Disease / psychology
  • Depressive Disorder / diagnosis
  • Depressive Disorder / epidemiology
  • Depressive Disorder / psychology*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / psychology
  • Geriatric Assessment
  • Hong Kong
  • Humans
  • Male
  • Nocturia / diagnosis
  • Nocturia / psychology*
  • Prostatic Hyperplasia / diagnosis
  • Prostatic Hyperplasia / epidemiology
  • Prostatic Hyperplasia / psychology*
  • Pulmonary Disease, Chronic Obstructive / diagnosis
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Pulmonary Disease, Chronic Obstructive / psychology
  • Quality of Life / psychology
  • Risk Factors
  • Sick Role
  • Smoking / adverse effects
  • Smoking / epidemiology
  • Smoking / psychology
  • Statistics as Topic
  • Urinary Bladder Neck Obstruction / diagnosis
  • Urinary Bladder Neck Obstruction / epidemiology
  • Urinary Bladder Neck Obstruction / psychology*
  • Urinary Retention / diagnosis
  • Urinary Retention / epidemiology
  • Urinary Retention / psychology*

Substances

  • Adrenal Cortex Hormones